Press Releases

Transaction Creates Preeminent Radiation Oncology Center

February 7, 2011

Benesch client, Oak Hill Capital Partners’ portfolio company, Physician Oncology Services LP (POSI) completed the combination of its business with the business of Vantage Oncology, Inc., creating one of the nation’s preeminent networks of outpatient radiation oncology centers. The combined company, named Vantage Oncology, will operate 40 radiation and oncology centers in 13 states nationwide, providing critical oncology services to more than 1,000 patients per day. The financial terms of the transaction, which closed on January 31, were not publicly disclosed.

Benesch served as health care regulatory counsel for Oak Hill Capital Partners and Physician Oncology Services LP for this transaction.

About Benesch
With offices in Cleveland, Columbus, Indianapolis, Philadelphia, Shanghai, White Plains and Wilmington, Benesch’s practice and industry groups include Business Reorganization, the China Group, Compensation & Benefits, Construction, Commercial Finance & Banking, Corporate & Securities, Litigation, Energy, Health Care, Intellectual Property, Labor & Employment, Polymer Industry, Private Equity, Public Finance, Public Law, Real Estate & Environmental, Tax, Transportation & Logistics, and Estate Planning & Probate. For more information, visit www.beneschlaw.com.

###

Latest News

Press Releases 9.10.26

Michael Chu Joins Benesch’s Intellectual Property Practice Group from McDermott Will & Schulte, Strengthening Patent Litigation Bench

Benesch is pleased to announce that Michael Chu has joined the firm as a partner in its growing Intellectual Property Practice Group in Chicago. His arrival marks the latest milestone in the continued expansion and success of a thriving practice that is building momentum across industries and technologies. Michael brings more than three decades of experience representing clients in complex patent and intellectual property disputes, as well as advising domestic and international companies on patent prosecution, intellectual property portfolio strategy, licensing, post-grant proceedings, trade and cross-border intellectual property matters.